Literature DB >> 16408227

Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681).

Mark Naunton, Michiel Duyvendak, Gregory M Peterson, Jacobus R J B Brouwers.   

Abstract

Mesh：

Year:  2006        PMID： 16408227     DOI： 10.1007/s00228-005-0074-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

2.  Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant.

Authors:  Bente Glintborg; Stig Ejdrup Andersen; Kim Dalhoff
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

3.  The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.

Authors:  Keyur B Shah; Krishnamurti Rao; Robert Sawyer; Stephen S Gottlieb
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

4.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

5.  Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.

Authors:  Suzan N Kucukarslan; Michael Peters; Mark Mlynarek; Daniel A Nafziger
Journal:  Arch Intern Med       Date:  2003-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.